|
|
| | 3,4-MDMA-d5 (hydrochloride) Basic information |
| Product Name: | 3,4-MDMA-d5 (hydrochloride) | | Synonyms: | 3,4-MDMA-d5 (hydrochloride);α-methyl-N-(methyl-d3)-1,3-benzodioxole-5-ethan-α,β-d2-amine,monohydrochloride;d,l-MDMA-D5.HCl, 1mg/ml in Methanol (as free base);d,l-MDMA-D5.HCl, 0.1mg/ml in Methanol (as free base);d,l-MDMA-D5.HCl | | CAS: | 2747917-97-9 | | MF: | C11H11ClD5NO2 | | MW: | 234.73404889 | | EINECS: | | | Product Categories: | | | Mol File: | 2747917-97-9.mol |  |
| | 3,4-MDMA-d5 (hydrochloride) Chemical Properties |
| solubility | DMSO: Sparingly soluble: 1-10 mg/ml
Ethanol: Slightly soluble: 0.1-1 mg/mlPBS (pH 7.2): Sparingly soluble: 1-10 mg/ml |
| | 3,4-MDMA-d5 (hydrochloride) Usage And Synthesis |
| Description | 3,4-MDMA-d5 (hydrochloride) (Item No. 42148) is intended for use as an internal standard for the quantification of 3,4-MDMA (Item Nos. ISO60190 | 13971 | 34480) by GC- or LC-MS. 3,4-MDMA is categorized as an amphetamine. 3,4-MDMA has been found in tablets seized by law enforcement and has been associated with overdoses.1,2 3,4-MDMA-d5 is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. | | References | [1] DAVID MICHAEL WOOD. Variability in the 3,4-methylenedioxymethamphetamine content of “ecstasy” tablets in the UK.[J]. Emergency Medicine Journal, 2011, 28 9: 764-765. DOI: 10.1136/emj.2010.092270
[2] PATIL ARMENIAN. Multiple MDMA (Ecstasy) overdoses at a rave event: a case series.[J]. Journal of Intensive Care Medicine, 2013, 28 4: 252-258. DOI: 10.1177/0885066612445982 |
| | 3,4-MDMA-d5 (hydrochloride) Preparation Products And Raw materials |
|